RT Journal Article
SR Electronic
T1 Effect of COVID-19 on <sup>18</sup>F-FDG PET/CT: Is There a Need to Consider COVID-19 Status Before Planning <sup>18</sup>F-FDG PET/CT for Oncologic Evaluation?
JF Journal of Nuclear Medicine Technology
JO J. Nucl. Med. Technol.
FD Society of Nuclear Medicine
SP 284
OP 285
DO 10.2967/jnmt.121.262145
VO 49
IS 3
A1 Kavanal, Anwin Joseph
A1 Jena, Santosh Ranjan
A1 Kumar, Rajender
A1 Das, Chandan Krushna
A1 Kumar, Sunil
A1 Mittal, Bhagwant Rai
YR 2021
UL http://tech.snmjournals.org/content/49/3/284.abstract
AB Incidental detection of coronavirus disease 2019 (COVID-19)–related lung changes on 18F-FDG PET/CT images of oncology patients has been increasingly reported. Most of the case reports or series have stressed the retrospective diagnosis of COVID-19 with the help of 18F-FDG PET/CT lung findings. In this case report, we introduce a different aspect of COVID-19–related lung changes on 18F-FDG PET/CT, interfering with the evaluation of metastatic lung lesions in a patient with renal cell carcinoma.